Heart Failure
Conference Coverage
Occult Left Ventricular Dysfunction Common in Type 2 Diabetes Patients
Major Finding: Left ventricular dysfunction was present in 60% of patients with type 2 diabetes, despite the absence of any clinical signs of...
News
Spironolactone's Heart Failure Benefit Outweighs Hyperkalemia Risk
Major Finding: Patients receiving spironolactone were more likely to develop hyperkalemia than were those on placebo (14.5% vs.
News
Heart Failure Hospitalization, Deaths Decline with Depression Intervention
Major Finding: Patients in the biobehavioral intervention group had a lower rate of cardiac hospitalization or death (28%) than their counterparts...
Conference Coverage
Quinine Doesn't Mix Well With Heart Failure, Ischemic Disease
Major Finding: Among patients with heart failure and ischemic heart disease on beta-blocker treatment, quinine dosing boosted mortality by 16%....
News
FDA Reviewing Possible Heart Failure Risk with Pramipexole
News
FDA Panel Votes Against Approval of Hyponatremia Drug
News
Nurse-Led Case Management Cuts HF Readmissions, Mortality
Major Finding: Case-management interventions led by a specialist nurse produced a substantial and highly significant reduction in all-cause...
News
Evidence Mounts on Heart Failure After Trastuzumab in Breast Cancer Survivors
Major Finding: The adjusted risk of heart failure (HF) and/or cardiomyopathy increased fourfold among women who received trastuzumab alone and...
Conference Coverage
Third Universal MI Definition Unveiled
Conference Coverage
LCZ696 Promising in Subset of Heart Failure Patients
Major Finding: The change in NT-proBNP from baseline to week 12 was significantly reduced in patients in the LCZ696 group (from 783 to 605 pg/mL...